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Abstract
Background—Posttraumatic stress disorder (PTSD) has been linked to hypertension, but most 
research on PTSD and hypertension is cross-sectional, and potential mediators have not been 
clearly identified. Moreover, PTSD is twice as common in women than in men, but understanding 
of the PTSD-hypertension relation in women is limited. We examined trauma exposure and PTSD 
symptoms in relation to incident hypertension over 22 years in 47,514 civilian women in the 
Nurses’ Health Study II.
Methods—We used proportional hazards models to estimate hazard ratios (HRs) and 95% 
confidence intervals (CIs) for new-onset hypertension (N=15,837).
Results—PTSD symptoms assessed with a screen were modestly associated with incident 
hypertension in a dose-response fashion after adjusting for potential confounders. Compared to 
women with no trauma exposure, women with 6–7 PTSD symptoms had the highest risk of 
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developing hypertension (HR=1.20 [95% CI, 1.12–1.30]), followed by women with 4–5 symptoms 
(HR=1.17 [95% CI, 1.10–1.25]), women with 1–3 symptoms (HR=1.12 [95% CI, 1.06–1.18]), and 
trauma-exposed women with no symptoms (HR=1.04 [95% CI, 1.00–1.09]). Findings were 
maintained, although attenuated, adjusting for hypertension-relevant medications, medical risk 
factors, and health behaviors. Higher body mass index and antidepressant use accounted for 30% 
and 21% of the PTSD symptom-hypertension association.
Conclusions—Screening for hypertension and reducing unhealthy lifestyle factors, particularly 
obesity, in women with PTSD may hold promise for offsetting cardiovascular risk.
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Introduction
In the U.S., over 40 million women have diagnosed hypertension, and the prevalence of 
hypertension in women has been rising in the last three decades (Mozaffarian et al., 2015). 
Hypertension is a major modifiable risk factor for cardiovascular disease (CVD), the leading 
cause of death in women (Mozaffarian et al., 2015). Recently, we demonstrated that elevated 
posttraumatic stress disorder (PTSD) symptoms were associated with increased CVD risk in 
younger and middle-aged women (Sumner et al., 2015). Better understanding of who is at 
risk for hypertension could inform CVD prevention efforts.
Exposure to trauma, including childhood abuse (Riley et al., 2010) and combat (Granado et 
al., 2009), has been associated with increased hypertension risk. PTSD, the sentinel trauma-
related disorder, has been tied to hypertension across numerous, and largely cross-sectional, 
studies (e.g., Abouzeid et al., 2012; Cohen et al., 2009; Davidson et al., 1991; Glaesmer et 
al., 2011; Kang et al., 2006; Lauterbach et al., 2005; O’Toole & Catts, 2008; Paulus et al., 
2013; Pietrzak et al., 2011; Sareen et al., 2007; Stein et al., 2014). Additionally, rates of 
metabolic syndrome—a constellation of cardiometabolic risk factors that includes 
hypertension—have been elevated in those with (vs. without) PTSD (e.g., Bartoli et al., 
2013). However, although PTSD is twice as common in women than in men (Kessler et al., 
1995), studies examining PTSD and hypertension in younger and middle-aged civilian 
women exposed to a range of traumas are generally lacking. Much research has been in 
predominantly male veteran samples (e.g., Abouzeid et al., 2012; Kang et al., 2006; O’Toole 
& Catts, 2008; Paulus et al., 2013; Schnurr et al., 2000; see Cohen et al., 2009, for an 
exception). Several studies have also suggested that PTSD is linked to increased 
hypertension risk in civilians (e.g., Davidson et al., 1991; Glaesmer et al., 2011; Lauterbach 
et al., 2005; Pietrzak et al., 2011; Sareen et al., 2007; Stein et al., 2014). However, relatively 
few of these civilian investigations have evaluated if the link between PTSD and 
hypertension is similarly evident in men vs. women; it is not yet clear whether associations 
hold in civilian women. One exception is the cross-sectional study by Pietrzak et al. (2011), 
which found that odds of hypertension were higher for men, but not women, with PTSD in 
the National Epidemiologic Survey on Alcohol and Related Conditions sample. Stein et al. 
(2014) also tested whether the PTSD-hypertension association was moderated by sex using 
the cross-sectional World Mental Health Surveys, although they did not present sex-stratified 
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results given the nonsignificant PTSD by sex interaction. Further studies are needed to 
understand if PTSD symptoms are associated with hypertension risk in women from the 
general population.
Furthermore, the effects of trauma with and without PTSD have rarely been considered in a 
single study. In a general population sample of German elderly individuals, trauma exposure 
without PTSD and current PTSD were cross-sectionally associated with increased 
hypertension risk compared to no trauma, although the magnitude of elevation in risk was 
greater for those with (vs. without) PTSD (Glaesmer et al., 2011). O’Toole and Catts (2008) 
also considered trauma and PTSD separately in their cross-sectional study of male veterans; 
only PTSD—not trauma alone—was associated with hypertension. Additional research 
examining effects of trauma and PTSD separately is needed, particularly in younger and 
middle-aged civilians.
Although research suggests a relation between PTSD and hypertension, the American Heart 
Association (2014) maintains that “stress is not a confirmed risk factor for high blood 
pressure (BP).” Virtually all PTSD-hypertension research has been cross-sectional 
(excepting Schnurr et al., 2000); longitudinal research is needed to demonstrate more 
convincingly that PTSD increases risk of, rather than is a consequence of, hypertension. 
Additionally, knowledge of mediating factors is limited. Mediating behavioral risk factors 
are likely given a sizeable proportion of incident hypertension can be reduced by addressing 
health behaviors, such as diet and exercise (Forman et al., 2009), and PTSD has been 
associated with obesity and unhealthy behaviors (e.g., Zen et al., 2012; Kubzansky et al., 
2014). Furthermore, antidepressants—frequently prescribed for PTSD (Friedman & 
Davidson, 2007)—have been linked to hypertension (Licht et al., 2009). Although several 
studies have adjusted for specific health behaviors (e.g., Schnurr et al., 2000), whether a 
range of health behaviors and antidepressant use can explain an observed PTSD-
hypertension relation is not known.
We addressed limitations in prior literature by examining associations between trauma 
exposure, PTSD symptoms, and risk of incident hypertension over 22 years in the Nurses’ 
Health Study II (NHS II), an ongoing longitudinal cohort study of younger and middle-aged 
women begun in 1989. A previous study in this cohort found that childhood abuse was 
associated with increased hypertension risk (Riley et al., 2010). Although PTSD could partly 
mediate the childhood abuse-hypertension relation, Riley et al. (2010) did not consider the 
psychological sequelae of early abuse. Here, we build on these findings by examining PTSD 
symptoms in response to a variety of traumas and incident hypertension. Additionally, we 
considered the effects of trauma and PTSD symptoms separately. We hypothesized that, 
compared to no trauma, higher PTSD symptoms would be related to increased risk of 
developing hypertension, after accounting for a range of potential confounders (determined 
from previous studies; e.g., Chasan-Taber et al., 1996; Gangwisch et al., 2013). Unlike most 
research on PTSD and hypertension, we also considered a range of potential mediators. We 
predicted that health behaviors and antidepressant use would explain some of this 
association.
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The NHS II includes 116,430 female nurses in the U.S., aged 25–42 years at enrollment in 
1989. Women complete questionnaires biennially; follow-up is ongoing. Supplemental 
questionnaires with special interests are periodically administered. In 2001, a supplemental 
questionnaire on violence exposure was mailed to 91,297 women and returned by 68,376 
women. In 2008, when participants were aged 44–62 years, 60,804 women who completed 
the 2001 Violence questionnaire and 2007 biennial questionnaire were mailed a 
supplemental questionnaire assessing trauma and PTSD (Morgan et al., 2001). After 
repeated mailings, 54,224 women returned the supplemental questionnaire (89% response 
rate). This study was approved by the Partners Healthcare Human Research Committee. 
Return of the questionnaire constituted implied consent. All procedures contributing to this 
work comply with the ethical standards of the relevant national and institutional committees 
on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.
Trauma and PTSD Symptom Assessment
PTSD symptom severity and age of onset were derived from information on trauma and 
PTSD symptoms. Trauma exposure was measured with a 16-item modified version of the 
Brief Trauma Questionnaire (Morgan et al., 2001; Schnurr et al., 1999), a reliable and valid 
measure of trauma exposure that parallels interview measures (Schnurr et al., 1999). 
Lifetime exposure to 15 traumatic events (e.g., natural disaster exposure, physical assault), 
in addition to “a seriously traumatic event not already covered,” was assessed. Respondents 
reported whether events occurred, which event occurred first, and which was their worst 
experience, along with their ages at the first and worst events. The Short Screening Scale for 
DSM-IV PTSD (Breslau et al., 1999) was used to assess whether women ever experienced 
seven PTSD symptoms in response to their worst trauma. Reliability of self-reported age-of-
onset of trauma and PTSD has been excellent in this sample (ICC=.95).
A time-varying variable characterizing women according to their trauma/PTSD symptom 
status was derived, with PTSD symptom onset dated according to the year women reported 
their worst trauma. For each study year, participants were classified into five groups based 
on their dates of trauma exposure and PTSD symptom severity: 1) no trauma exposure, 2) 
trauma-exposed with no PTSD symptoms, 3) trauma-exposed with 1–3 symptoms, 4) 
trauma-exposed with 4–5 symptoms, and 5) trauma-exposed with 6–7 symptoms. Before 
their first trauma (if reported), women were categorized as having no trauma exposure. After 
their first trauma, women were classified as being trauma-exposed with no symptoms. 
Following their worst trauma, women were classified as being trauma-exposed with the 
number of PTSD symptoms reported subsequent to the worst event. If women reported only 
one event, the years of the first and worst traumas were identical. In other words, if no 
trauma was ever reported, women were classified as having no trauma at all follow-up 
waves. Prior to reporting trauma, women were classified as having no trauma at all waves 
until trauma or trauma and PTSD symptoms were reported. Once trauma/PTSD symptom 
onset was reported, the severity of trauma/PTSD symptoms at onset was carried through all 
subsequent waves.
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Trauma/PTSD symptom categorizations were selected based on previous research with the 
Short Screening Scale for DSM-IV PTSD recommending scores of 4+ (Breslau et al., 1999) 
and 6+ (Kimerling et al., 2006) as clinical cutoffs for PTSD. Following this rubric resulted 
in one group of women with trauma and subclinical PTSD symptoms and two groups of 
women with trauma and PTSD symptom counts above the recommended clinical cutoff on 
this screening questionnaire, with the latter two grouped according to increasing symptom 
severity. With this nuanced classification rubric, we could examine hypertension onset in 
women with no trauma, trauma and no symptoms, and trauma and varying symptom 
severity.
Hypertension Assessment
Women reported lifetime physician-diagnosed hypertension at baseline in 1989. At each 
subsequent biennial questionnaire, participants indicated whether they had physician-
diagnosed hypertension in the past 2 years. Self-reported hypertension has been validated in 
this cohort. In randomly-chosen NHS II participants self-reporting hypertension, 94% had 
confirmed hypertension (Forman et al., 2008). Moreover, BP was measured in an age-
stratified sample of 194 NHS II participants to examine unreported hypertension. Of the 161 
women not reporting hypertension, only 11 (7%) had a BP>140/90mmHg. None had a 
BP>160/95mmHg (Chasan-Taber et al., 1996). For this study, women who reported ever 
having hypertension at the baseline assessment were excluded. We considered incident 
hypertension reported on the 1991–2011 questionnaires.
Covariates
Potential confounders included age at baseline, race/ethnicity (African American, Latina, 
Asian, Caucasian, other), maximum parental education at the participant’s birth (high school 
or less, some college, 4+ years of college), maternal and paternal history of hypertension, 
and age 5 somatotype (to estimate childhood adiposity). Time-varying indicators for 
hypertension-relevant medical risk factors and medications were included as biomedical 
covariates; all were assessed biennially unless otherwise indicated (see Figure 1 for study 
timeline). These included: oral contraceptive use (never used, current user, former user; 
Chasan-Taber et al., 1996); menopausal status and hormone therapy (HT) use (pre-
menopausal, post-menopausal/never HT, post-menopausal/past HT, post-menopausal/current 
HT, post-menopausal/missing HT, unknown menopausal status; Gangwisch et al., 2013); 
current aspirin use, acetaminophen use, and other nonsteroidal anti-inflammatory drug 
(NSAID) use (these were assessed with each biennial questionnaire except in 1991; 
Gangwisch et al., 2013); physician-diagnosed hypercholesterolemia.
Health behaviors were examined as potential mediators of the PTSD symptom-hypertension 
relation. These were time-varying covariates, assessed at baseline via self-report and updated 
biennially, unless otherwise noted (see Figure 1). Adult body mass index (BMI) in kg/m2 
was computed from self-reported height and weight (validated in NHS research; Rimm et 
al., 1990), and categorized as <18.5,18.5–<21,21–<23,23–<25,25–<27,27–<30, and 30+ 
(Munger et al., 2009). Participants were classified as nonsmokers, former smokers, or 
current smokers of 1–14,15–24, or 25+ cigarettes/day. Alcohol consumption (0,1–<5,5–
<10,10–<20,20+ grams/day) was assessed in 1989, 1991, 1995, 1999, 2003, and 2007. 
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Physical activity (<3,3–<9,9–<18,18–<27,27+ metabolic equivalent hours/week) was 
measured in 1989, 1991, 1997, 2001, 2005, and 2009. Diet quality based on the Alternative 
Healthy Eating Index (Chiuve et al., 2012) was assessed every 4 years beginning in 1991. 
Diet quality was divided into quintiles; the highest quintile represented the healthiest diet. 
Sugar-sweetened and artificially-sweetened beverage consumption were each categorized as 
<1/month, 1–4/month, 2–6/week, and 1+/day (Cohen et al., 2012). Lifetime antidepressant 
use was assessed in 1993, and regular past 2-year antidepressant use was assessed in 1997, 
2001, 2003, 2005, 2007, and 2009. Women endorsing lifetime use in 1993 were coded as 
using antidepressants from 1989–1993; use was updated as available.
Sensitivity Analyses
Childhood abuse has been associated with hypertension in the NHS II (Riley et al., 2010), 
and meta-analytic evidence has linked depression (often comorbid with PTSD) with incident 
hypertension (Meng et al., 2012). We examined potential confounding by childhood abuse 
and lifetime depression. Sexual abuse before age 18 was measured in 2001 with four 
questions regarding unwanted sexual touching or forced/coerced sexual contact by an adult 
or older child (Moore et al., 1995), and categorized as no sexual abuse, sexual touch only, or 
forced sex (Sumner et al., 2015). Childhood physical abuse was assessed in 2001 with the 
revised Conflict Tactics Scale (Straus & Gelles, 1990), and classified as none, mild, 
moderate, or severe (Sumner et al., 2015). Lifetime depression (experiencing depressive 
symptoms for 2+ weeks) was assessed in 2001, and women reported experiencing depressive 
symptoms for 2+ weeks or receiving a depression diagnosis in 2003, 2005, 2007, and 2009. 
Lifetime depression was assigned if women reported ever having depressive symptoms for 
2+ weeks or receiving a depression diagnosis.
Exclusions
Figure 2 shows exclusions for deriving the analytic sample (N=47,514). Compared to those 
in the analytic sample, women who returned the trauma/PTSD questionnaire but were 
excluded from analyses were slightly older at baseline (35.6 vs. 34.7 years), had higher rates 
of maternal (37.6% vs. 29.8%) and paternal (36.7% vs. 30.1%) hypertension and childhood 
adiposity (highest somatotype: 8.9% vs. 6.6%), and had parents with lower educational 
attainment (maximum parental education of high school or less: 50.3% vs. 47.1%). 
Cumulative incidence of hypertension (1989–2011) was similar for those included (33.5%) 
vs. excluded (34.0%).
Statistical Analyses
We examined whether trauma and PTSD symptoms were associated with incident 
hypertension with Cox proportional hazards models to calculate hazard ratios (HRs) and 
95% confidence intervals (CIs). Trauma/PTSD symptom status was considered a time-
varying variable, and trauma/PTSD symptom status for each year of follow-up was 
determined based on the year women reported experiencing their worst trauma. SAS PROC 
PHREG was used for analyses (SAS Institute, Cary, NC). The Andersen-Gill data structure 
was utilized because it can accommodate updating time-varying exposures and covariates, 
left-censored data, and potentially discontinuous intervals of risk (Therneau, 1997). With the 
Andersen-Gill data structure, a new data record was created for every questionnaire cycle 
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when a participant was at risk, with covariates set to their values at the time the 
questionnaire was returned. This method accounts for the nested structure of our data; it 
allows explicitly for correlated data, multiple time scales, and, if needed, multiple events per 
subject (Therneau, 1997). Participants contributed person-time (in months) from baseline in 
1989 until hypertension onset, death, end of follow-up in 2011, or their last questionnaire (if 
they did not return the 2011 questionnaire). Individuals who developed CVD (myocardial 
infarction or stroke) during the study (n=242) were censored at CVD onset.
We tested a series of models that first adjusted for demographic confounders, further 
adjusted for hypertension-relevant biomedical covariates, and further adjusted for potential 
mediators. Model 1 adjusted for demographics, family history, and childhood adiposity. 
Model 2 further adjusted for hypertension-relevant medical risk factors and medications. 
Model 3 additionally adjusted for health behaviors. Model 4 further adjusted for 
antidepressant use. Missing data in covariates were handled by treating missing as a separate 
category. Variables added in Models 2–4 (i.e., hypertension-relevant medical risk factors, 
medications, health behaviors) were time-varying and updated every 2, 4, or 6 years as 
available. For each period of prediction, variables added in Models 2–4 were lagged by one 
period, and trauma/PTSD symptom status was lagged to represent the year prior to the 
period for the Model 2–4 covariates. For example, for hypertension status on the 1993 
questionnaire, covariates added in Models 2–4 (including proposed mediators) were derived 
from the 1991 questionnaire, and trauma/PTSD symptoms reflected status in 1990. The 
outcome for the final period of prediction was hypertension status on the 2011 questionnaire, 
with trauma/PTSD symptoms characterized/updated only through 2008 (when the trauma/
PTSD questionnaire was administered). To assess which trauma/PTSD symptom groups 
differed significantly from one another, we varied the reference group in further analyses 
using the same modeling strategy described above.
Health behaviors (e.g., smoking, diet), BMI, and antidepressant use were examined as 
potential mediators. We first considered their separate associations with trauma/PTSD 
symptoms using generalized estimating equations (trauma/PTSD symptoms and potential 
mediators were time-varying variables that were updated over the course of the study 
period). We also considered separate associations of potential mediators with hypertension 
risk using Cox proportional hazards models. We then tested for mediation by adding each 
variable individually to Model 2. Attenuation ≥10% in trauma/PTSD symptom parameter 
estimates after including the hypothesized mediator was used as a cutoff considered 
sufficient to be consistent with mediation (Gangwisch et al., 2013). We examined the percent 
of the PTSD symptom-hypertension relation accounted for by potential mediators using the 
SAS Mediate macro (2009), which calculates point estimates and 95% CIs of the percent of 
exposure explained by each intermediate variable.
We conducted three sensitivity analyses. We tested for potential confounding by childhood 
abuse and depression by re-estimating Model 1 adjusting for each relevant indicator. 
Additionally, because many hypertension events occurred before assessing trauma/PTSD 
symptoms in 2008, we considered the possible impact of recall bias by analyzing 
prospectively detected new-onset hypertension events reported on the 2009 and 2011 
questionnaires (N=35,187; 3,554 hypertension events).
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Table 1 presents participant characteristics by trauma and PTSD symptom status at baseline. 
Many women (69%) reported trauma by 1989. Of trauma-exposed participants at baseline, 
73% reported no PTSD symptoms, 14% reported 1–3 symptoms, 8% reported 4–5 
symptoms, and 5% reported 6–7 symptoms. Over the study, 5,144 additional women 
reported trauma exposure.
Over the 22-year study period, 15,837 women developed hypertension. Time-updated PTSD 
symptoms were modestly associated with increased risk of incident hypertension in a dose-
response fashion. Women with 6–7 PTSD symptoms had a 20% higher rate of developing 
hypertension compared to women without trauma, after adjusting for demographics, family 
history, and childhood adiposity (Table 2, Model 1; see Figure 3 for survival curves). 
Analyses considering different reference groups indicated that the HRs for the no trauma 
and trauma/no symptoms groups were lower than those for all PTSD symptom groups; 
however, the PTSD symptom groups did not differ significantly from each other 
(Supplementary Table 1). Findings remained significant, although attenuated, after adjusting 
for time-varying hypertension-relevant medical risk factors and medications (Table 2, Model 
2; Supplementary Table 2 includes HRs for hypertension risk associated with Model 2 
covariates). Despite additional attenuation after adjusting for time-updated health behaviors, 
PTSD symptoms remained associated with significantly elevated hypertension risk (Table 2, 
Model 3). Covarying time-varying antidepressant use attenuated associations further, 
particularly for women with 6–7 symptoms (Table 2, Model 4).
As all potential mediators were significantly associated with trauma/PTSD symptoms and 
hypertension risk (Supplementary Table 3), all were included as described above in pathway 
models. However, as only two potential mediators—BMI and antidepressant use—resulted 
in ≥10% attenuation in trauma/PTSD symptom parameter estimates in relation to 
hypertension risk, we present only findings for these variables. Results of generalized 
estimating equations indicated higher PTSD symptoms were associated with higher BMI 
and greater likelihood of antidepressant use (Supplementary Table 3). BMI and 
antidepressant use were significantly associated with hypertension risk, after adjusting for 
demographics, family history, and childhood adiposity. Increasing BMI was monotonically 
related to elevated hypertension risk, with the largest increases in risk observed for BMI of 
27+ (Supplementary Table 3). Antidepressant use (vs. non-use) was also associated with 
increased risk of hypertension (Supplementary Table 3). In models adjusting for all other 
covariates, BMI accounted for an estimated 30% (95% CI, 12–57%) and antidepressant use 
accounted for an estimated 21% (95% CI, 9–43%) of the PTSD symptom-hypertension 
association.
After including childhood abuse in Model 1, PTSD symptoms remained associated with 
elevated hypertension risk (trauma/no symptoms: HR=1.02 [95% CI, 0.98–1.06]; trauma/1–
3 symptoms: HR=1.09 [95% CI, 1.03–1.15]; trauma/4–5 symptoms: HR=1.12 [95% CI, 
1.05–1.19]; trauma/6–7 symptoms: HR=1.13 [95% CI, 1.05–1.22]). When including lifetime 
depression with Model 1 covariates, PTSD symptoms remained significantly associated with 
hypertension risk, although HRs were attenuated (trauma/no symptoms: HR=1.03 [95% CI, 
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0.99–1.07]; trauma/1–3 symptoms: HR=1.08 [95% CI, 1.02–1.14]; trauma/4–5 symptoms: 
HR=1.10 [95% CI, 1.03–1.17]; trauma/6–7 symptoms: HR=1.11 [95% CI, 1.03–1.20]).
In the analysis predicting 3,554 prospectively detected hypertension events after 2008 
(adjusted for Model 1 covariates), higher PTSD symptoms were associated with increased 
hypertension risk (trauma/no symptoms: HR=0.98 [95% CI, 0.90–1.07]; trauma/1–3 
symptoms: HR=1.05 [95% CI, 0.94–1.17]; trauma/4–5 symptoms: HR=1.11 [95% CI, 0.98–
1.26]; trauma/6–7 symptoms: HR=1.10 [95% CI, 0.95–1.28]). Findings did not reach 
statistical significance, likely due to limiting to cases that onset when women were older.
Discussion
We present the first study of PTSD symptoms and incident hypertension in women that 
utilizes a longitudinal population-based cohort and examines potential mediators. PTSD 
symptoms were modestly associated with increased risk of developing hypertension over 22 
years. Effect sizes were largest for the highest PTSD symptom levels, although confidence 
intervals for the different PTSD symptom groups were overlapping. BMI and antidepressant 
use emerged as mediators, accounting for an estimated 30% and 21% of the PTSD 
symptom-hypertension relation. Elevated PTSD symptoms have been associated with 
myocardial infarction and stroke incidence in women (Sumner et al., 2015); increasing 
hypertension risk may be one mechanism by which PTSD contributes to these diseases.
Cross-sectional studies have documented associations between PTSD and hypertension but 
they have not been able to address whether PTSD precedes hypertension (e.g., Abouzeid et 
al., 2012; Pietrzak et al., 2011). Our investigation expands this literature by examining PTSD 
symptoms in relation to hypertension onset—assessed longitudinally—over 22 years. PTSD 
symptoms were significantly associated with developing hypertension, even when adjusting 
for factors related to PTSD that have been linked to hypertension, including childhood abuse 
and lifetime depression (Riley et al., 2010; Meng et al., 2012). Our findings are consistent 
with research suggesting that the PTSD-hypertension relation does not solely reflect risk 
associated with comorbid depression (Kibler et al., 2009). Furthermore, our study extends 
previous research by 1) examining the association between PTSD symptoms and incident 
hypertension in younger and middle-aged civilian women, 2) considering effects of trauma 
and PTSD symptoms separately, 3) utilizing a longitudinal design, and 4) considering a 
range of potential mediators.
PTSD symptoms remained associated with hypertension risk when predicting prospectively 
detected new-onset hypertension, although findings were not statistically significant. This 
analysis predicted cases that onset when women were older (44–66 years), which may 
explain the lack of statistical significance. Hypertension becomes more common as women 
age (Mozaffarian et al., 2015). With increasing age, more hypertension risk factors are at 
play, making it harder to disentangle differential risk and detect relative effects. We believe it 
is suggestive that we detected any elevated risk in this subsample, particularly because we 
had a shorter timeframe in which to examine the PTSD symptom-hypertension relation.
Sumner et al. Page 9













We identified two behavior-related risk factors as potential mediators of the PTSD symptom-
hypertension association: BMI and antidepressant use. Even modest weight gain has been 
associated with increased hypertension risk in women (Huang et al., 1998), and women with 
PTSD symptoms are at risk of becoming overweight and obese (Kubzansky et al., 2014). 
Weight loss reduces hypertension risk (Huang et al., 1998); thus it may be important to 
consider benefits of weight loss among women with PTSD who are overweight or obese. 
Additionally, our finding that antidepressant use accounted for a portion of the PTSD 
symptom-hypertension relation is consistent with research suggesting antidepressant use 
may partly explain the link between PTSD symptoms and chronic disease (e.g., Type 2 
diabetes; Roberts et al., 2015). Antidepressant use may indicate greater PTSD severity rather 
than be a mediator. In our sample, higher PTSD symptoms were associated with greater 
likelihood of antidepressant use. Additionally, antidepressants have been found to influence 
BP, in part, by affecting vagal control (Licht et al., 2009).
Additional behavioral and biological mediating risk factors not captured by the health 
behaviors examined likely also underlie the PTSD symptom-hypertension relation and merit 
investigation. For example, sleep disturbances are associated with hypertension in women 
(Cappuccio et al., 2007), and are commonly reported by individuals with PTSD (Maher et 
al., 2006). PTSD is also characterized by dysregulation of the autonomic nervous system, 
hypothalamic-pituitary-adrenal axis, and inflammatory response (Zoladz & Diamond, 2013), 
which could increase hypertension risk. For example, sympathetic nervous system 
hyperactivity (e.g., as indicated by elevated norepinephrine levels; Zoladz & Diamond, 
2013) has been observed in PTSD. Sympathetic overdrive has been implicated in elevated 
BP onset and the progression and increased severity of hypertension over time (Mancia & 
Grassi, 2014).
Methodological limitations of this study include the retrospective assessment of trauma and 
lifetime PTSD symptoms via screener and the derivation of date of symptom onset based on 
the date of the worst trauma (to which symptoms were anchored). Nevertheless, we were 
able to use this information as a time-varying variable in our models, with trauma/PTSD 
symptom status updated only through 2008. Dating of trauma has been reliable in this 
sample, but precision of reports may be somewhat lower than contemporaneous report. To 
avoid concerns about potential reverse causality, we lagged the trauma/PTSD symptom 
exposure so measures of potential mediators occurred one period after exposure date and 
hypertension status was evaluated two periods after exposure date. This approach could lead 
to underestimated results if disease-related effects of trauma/PTSD symptoms appear a few 
years after trauma/PTSD onset. Furthermore, our study does not address how remission of 
PTSD symptoms might impact risk of hypertension. If hypertension risk declines once 
PTSD symptoms remit, our findings may underestimate the strength of the PTSD symptom-
hypertension association. Further research is needed to explore this topic. Another limitation 
is the self-reported hypertension outcome, although it has been validated in this cohort 
(Chasan-Taber et al., 1996; Forman et al., 2008). Survivor bias is potentially a concern 
because women needed to remain in the study until 2008 to provide trauma/PTSD data. 
However, study retention is high (>90% biennial questionnaire response rate), and only 
1.6% of the cohort (n=1,826) was deceased by trauma/PTSD symptom assessment. 
Generalizability of findings may be limited as the NHS II cohort is predominantly white and 
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highly educated. However, findings are consistent with cross-sectional studies in more 
diverse samples (Davidson et al., 1991; Pietrzak et al., 2011). Despite these limitations, this 
study is characterized by several unique strengths. It is the largest study of PTSD symptoms 
and hypertension in women to date and uses longitudinal data, thereby reducing concerns 
about reverse causality. We are the first study to our knowledge to evaluate the PTSD 
symptom-hypertension relation in civilian women exposed to various traumas after 
accounting for a substantial set of potential confounders. Further, we tested a broad range of 
previously hypothesized mediators.
Conclusions
Approximately 1 in 10 women develop PTSD in their lifetime. Our study suggests that 
PTSD symptoms not only affect women’s mental health but also their cardiovascular health. 
These findings, along with results linking PTSD symptoms to myocardial infarction and 
stroke (Sumner et al., 2015), indicate that women with PTSD symptoms may be particularly 
susceptible to cardiovascular dysfunction, and this may suggest the value of targeted 
surveillance of individuals with PTSD to improve early detection of cardiovascular risk. A 
key goal of future research is to determine whether successful PTSD treatment reduces 
hypertension. Ultimately, it is clear that the impact of PTSD does not end with the mind but 
extends to the heart.
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Timeline of variables collected at biennial assessments. HTN=hypertension. BMI=body 
mass index. OC=oral contraceptive use. HT=hormone therapy use. NSAID=nonsteroidal 
anti-inflammatory drug. ADM=antidepressant medication. Response rates for the analytic 
sample are listed for each time point. Trauma/PTSD symptom status was assigned for each 
year of the study and updated based on reported age of worst trauma (assessed with a 
supplemental questionnaire in 2008).
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Exclusions for deriving the analytic sample.
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Survival by trauma/PTSD symptom status, 1989–2011. Model adjusted for age at baseline, 
race/ethnicity, parental education, maternal and paternal history of hypertension, and 
somatotype at age 5.
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